Skip to main content

Month: June 2021

Advicenne provides an update on its activities following its Annual General Meeting

Advicenne provides an update on its activities followingits Annual General MeetingIntroducing Advicenne 2.0, the Company’s strategy to unlock value Poised to partner Sibnayal in dRTA in Europe following EMA marketing authorization Accelerate clinical development of Sibnayal™ in the US to maximize value creation Reinforce the management team to deliver Advicenne 2.0 goalsPARIS, France, 17:45 p.m. CET, June 15, 2021 – Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, provides an update on its activities following its Annual General Meeting, which was held virtually on June 14, 2021. During the Annual General Meeting, a majority of shareholders voted for all resolutions as recommended by the Board of Directors....

Continue reading

Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel

Testing will be available through CLX Health’s TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to travel.  COVID-19 tests can be scheduled online and are available at Enzo’s patient service center locations throughout New York and New Jersey with no waiting and rapid results. NEW YORK, NY, June 15, 2021 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, and CLX Health, developer of cloud-based solutions to manage the COVID-19 testing ecosystem through its TrustAssure™ Global Network, today announced a new collaboration to provide rapid access in New York and New Jersey to COVID-19 PCR testing that will be required for international travel from the U.S. to destinations...

Continue reading

WISeKey’s TrustedNFT Platform to Turn Patents into Non-Fungible Tokens (NFT) and Store Them on an Identity Blockchain Network

WISeKey’s TrustedNFT Platform to Turn Patents into Non-Fungible Tokens (NFT) and Store Them on an Identity Blockchain Network WISeKey is inviting companies and individuals holding patents to join its NFT patent ecosystem powered by the extensive list of patents owned by the company (https://www.wisekey.com/company/our-value-proposition/our-patents/) GENEVA – June 15, 2021: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI, Blockchain and IoT company, today announced during the Geneva Trust in Innovation Summit https://summit.trustininnovation.com/ that has developed functionality on its TrustedNFt.IO platform to tokenize patents allowing intellectual property to be treated as unique business assets, making patents easier to license, sell and commercialize. WISeKey uses a unique...

Continue reading

Albioma : Disclosure of trading in own shares – Period from 9 June 2021 to 11 June 2021

Press release Paris La Défense, 15 June 2021 Disclosure of trading in own shares Period from 9 June 2021 to 11 June 2021 Albioma declares that from 9 June 2021 to 11 June 2021, it carried out the following transactions in its own shares under the share buyback programme authorised by the Combined General Meeting of 25 May 2021, presented in aggregate form:Name of issuer LEI code Day of transaction ISIN code Total daily volume (in number of shares) Daily wieghted average acquisition price Market identification codeALBIOMA 9695002W8GRJRZ44MA62 09/06/2021 FR0000060402 10,000 34.0785 XPARALBIOMA 9695002W8GRJRZ44MA62 10/06/2021 FR0000060402 12,628 33.4159 XPARALBIOMA 9695002W8GRJRZ44MA62 11/06/2021 FR0000060402 10,282 33.4038 XPAR        32,910 33.6135  A detailed list of transactions is available on the Company’s website,...

Continue reading

Precision Drilling Corporation Announces Closing of Offering of US$400,000,000 of 6.875% Senior Notes Due 2029 and Redemption of 7.75% Senior Notes Due 2023 and 5.25% Senior Notes Due 2024

CALGARY, Alberta, June 15, 2021 (GLOBE NEWSWIRE) — Precision Drilling Corporation (“Precision” or the “Company”) announced today the closing of its previously announced private offering of US$400 million aggregate principal amount of 6.875% Senior Notes due 2029 (the “Notes”), issued at a price equal to 99.253% of the face value, in a transaction that was exempt from the registration requirements of the U.S. Securities Act of 1933, as amended (the “Securities Act”). The Notes are guaranteed on a senior unsecured basis by current and future U.S. and Canadian subsidiaries of Precision that also guarantee Precision’s revolving credit facility and certain other future indebtedness. As previously announced, Precision will use the net proceeds from the offering, together with unutilized capacity under its revolving credit facility to:...

Continue reading

DIAGNOS Announces a Pilot with Hospital Oftalmológico Buena Vista Sinaloa

BROSSARD, Quebec, June 15, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena Vista Sinaloa, the largest ophthalmological hospital in Sinaloa State, Mexico. In Mexico there are 18 million diabetics with a 23% prevalence in people of 20 years or more; the seriousness of these cases is that every hour in the country eight patients die from this disease, since 80% of deaths in Mexico, is related to diabetes. In Sinaloa State, 355,000 thousand cases are reported, of which almost half (175,000) are undiagnosed, with a prevalence of 21% of the population of 20 years or more. Of the 180,000 diagnosed for diabetes, only 30% go to the doctor on a regular...

Continue reading

XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies

VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) — via InvestorWire — XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers XPhyto’s recent announcement regarding the status of its GMP mescaline synthesis program. To hear the audio production, visit: https://www.nnw.fm/GFUhh To read the original press release, visit: https://www.nnw.fm/dcaCA “With both its North American GMP mescaline synthesis...

Continue reading

Lightbridge Corporation to Join Russell Microcap® Index

RESTON, Va., June 15, 2021 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that it will be added to the Russell Microcap® Index after the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, according to a preliminary list of additions posted June 4. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes. Seth Grae, President and CEO of Lightbridge, commented, “We are proud to be included in the Russell Microcap® Index this year, particularly as one of the few publicly traded nuclear...

Continue reading

Precipio Terminates its Equity Line

NEW HAVEN, Conn., June 15, 2021 (GLOBE NEWSWIRE) — Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces that as part of management’s review of its current financing arrangements, it has terminated the equity line financing structure it had in place with Lincoln Park Capital. The equity line was used by Precipio to fund day-to-day operations and cover its operational cash burn that was required for the Company’s continued growth. With the Company’s current situation – growing revenues, improved gross margins, improving cash from gross profits – combined with our current cash position, management currently does not anticipate the need for additional capital raises of the type that Lincoln Park has provided us. “I’d like to thank our friends at Lincoln Park Capital for their help and support of the Company,...

Continue reading

Jamf Continues its Investment in its Enterprise Security Platform, Empowering Both Organizations and Individuals to Be Productive and Protected

The company releases passwordless authentication workflow, launches simplified compliance solution, and advances Apple threat security research MINNEAPOLIS, June 15, 2021 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in Apple Enterprise Management, recently announced a series of new security capabilities to help organizations secure company data and stay compliant with company policies, while empowering their employees to seamlessly access what they need to be their best. Giving End Users Easy but Secure Access to Workplace Tools Stolen or compromised passwords are a security threat now more than ever. IT admins try to combat this threat with password policies, but strong passwords can be difficult for users to remember, and passwords are often reused for multiple resources, increasing vulnerability.  Jamf has expanded on...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.